Update shared on 11 Dec 2025
Fair value Increased 20%Analysts have raised their price target for Eneva from R$17.01 to R$20.35, citing modest improvements in expected revenue trends, a slightly lower discount rate, and a higher future P/E multiple despite a marginally softer projected profit margin.
Valuation Changes
- Fair Value: Raised from R$17.01 to R$20.35, representing a moderate upward revision in the estimated intrinsic value.
- Discount Rate: Reduced slightly from 20.50 percent to 20.32 percent, reflecting a marginally lower perceived risk or cost of capital.
- Revenue Growth: Improved modestly from an expected contraction of 8.53 percent to a slightly smaller decline of 8.49 percent.
- Net Profit Margin: Trimmed slightly from 24.81 percent to 24.24 percent, indicating a small reduction in projected profitability.
- Future P/E: Increased from 17.0x to 20.7x, implying a higher valuation multiple being applied to forward earnings.
Have other thoughts on Eneva?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.